49 results
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Act of 2002 and Item 406 of Regulation S-K. In addition, we intend to promptly disclose (1) the nature of any substantive amendment to our Code … or persons performing similar functions and (2) the nature of any waiver, including an implicit waiver, from a provision of our code of ethics
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
DISCRETIONARY IN NATURE AND IS NOT TO BE CONSIDERED PART OF ANY NORMAL OR EXPECTED COMPENSATION THAT IS OR WOULD BE SUBJECT TO SEVERANCE, RESIGNATION … to the Offer for eligible employees and directors subject to tax in Switzerland. This discussion is general in nature and does not discuss all of the tax
D
gb5f4
7 Nov 23
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
12:03pm
8-K
EX-10.1
ns3oop8 a1
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-4.2
dcqc1c
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
CORRESP
gvv e3lyae8tnh
22 Dec 22
Correspondence with SEC
12:00am
UPLOAD
1911i7
8 Dec 22
Letter from SEC
12:00am